Director
Department of Diabetes & Endocrinology
NOVO Nordisk
Austria
Mr. Helge Lund has been Director of Novo Nordisk A/S since March 23, 2017. He was previously Independent Director of the Company from March 20, 2014 till March 19, 2015. He formerly served as CEO of Statoil ASA, Norway. He has been Chief executive officer of BG Group, UK, with effect from March 2, 2015. He has executive and board experience in large multinational companies headquartered in Scandinavia within regulated markets, and financial knowledge. He holds Master of Arts in Economics (1987) from the Norwegian School of Economics & Business Administration (NHH) and MBA from INSEAD (1991), France.
Diabetes, Endocrinology, Pharma, Research, Medical